(Q40363090)

English

Mutations other than 103N in human immunodeficiency virus type 1 reverse transcriptase (RT) emerge from K103R polymorphism under non-nucleoside RT inhibitor pressure

scientific article published on 10 October 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Mutations other than 103N in human immunodeficiency virus type 1 reverse transcriptase (RT) emerge from K103R polymorphism under non-nucleoside RT inhibitor pressure (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

4

object named as

Shinichi Oka

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

Hiroyuki Gatanaga

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Atsuko Hachiya

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Satoshi Kimura

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

language of work or name

0 references

publication date

10 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

344

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

354-362

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Resistance to non-nucleoside inhibitors of HIV-1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

Comprehensive mutant enzyme and viral variant assessment of human immunodeficiency virus type 1 reverse transcriptase resistance to nonnucleoside inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

Competitive fitness of nevirapine-resistant human immunodeficiency virus type 1 mutants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

Polymorphism and drug-selected mutations in the protease gene of human immunodeficiency virus type 2 from patients living in Southern France

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

Amino acid substitutions in Gag protein at non-cleavage sites are indispensable for the development of a high multitude of HIV-1 resistance against protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

Rapid and simple phenotypic assay for drug susceptibility of human immunodeficiency virus type 1 using CCR5-expressing HeLa/CD4(+) cell clone 1-10 (MAGIC-5)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

"All-in-One Assay", a direct phenotypic anti-human immunodeficiency virus type 1 drug resistance assay for three-drug combination therapies that takes into consideration in vivo drug concentrations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

Novel patterns of nevirapine resistance-associated mutations of human immunodeficiency virus type 1 in treatment-naïve patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

Rare mutations at codon 103 of HIV-1 reverse transcriptase can confer resistance to non-nucleoside reverse transcriptase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

4'-Ethynyl nucleoside analogs: potent inhibitors of multidrug-resistant human immunodeficiency virus variants in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

Human immunodeficiency virus reverse transcriptase and protease sequence database

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

Multiple drug resistance to nucleoside analogues and nonnucleoside reverse transcriptase inhibitors in an efficiently replicating human immunodeficiency virus type 1 patient strain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

Selection conditions affect the evolution of specific mutations in the reverse transcriptase gene associated with resistance to DMP 266.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

In vitro induction of human immunodeficiency virus type 1 variants resistant to phosphoralaninate prodrugs of Z-methylenecyclopropane nucleoside analogues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

pol gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro induction of human immunodeficiency virus type 1 variants resistant to 2'-beta-Fluoro-2',3'-dideoxyadenosine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.005

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2005.09.005

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40363090&oldid=1896200655"